The stock has fallen from a peak back in April.

The long-term prospects for these stocks look especially bright.

If you have ever wondered whether Vertex Pharmaceuticals is a bargain right now, you are not alone. Let's break down whether the current price really stacks up to the company's fundamentals. Despite ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Vertex Pharmaceuticals has seen its fair value estimate inch up from about $480 to roughly $485 per share as analysts refresh their models around a more constructive long term growth narrative.

Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...

Shopify and Google Cloud are teaming up to redefine the future of e-commerce with real, practical AI tools that deliver ROI ...

Indian Tech Firms Find New Frontier In UAE's Booming Proptech Sector. As India's tech-solution providers push beyond ...

HSE has been advised the drug is not value for money ...

Google's latest Gemini upgrade moves voice closer to a central interaction mode for Search, adding a new wrinkle to SEO.

Academic aid from employers includes help mapping out college finances, finding scholarship applications, getting your child ...

Researchers have discovered that cooling starchy foods—from pizza to rice—creates “resistant starch,” a carb that behaves like fiber and alters your blood sugar response ...